| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228910 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
CRT is effective for Stage II-III ESCC with manageable acute toxicities and can provide a nonsurgical treatment option. However, further improvement is required for reduction in late toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ken M.D., Kei M.D., Keiko M.D., Atsushi M.D., Satoshi M.D., Narikazu M.D., Hiroya M.D., Yoshito M.D., Yoshinori M.D., Haruhiko M.D.,